Australija - anglų - Department of Health (Therapeutic Goods Administration)

arthrex australia pty ltd - 45061 - fixation anchor, soft-tissue, biodegradable - the device is comprised of two sections, an absorbable anchor body of plla and ?tcp and a non-absorbable closed peek eyelet. the suture anchor is pre-mounted on a driver with the anchor body and eyelet physically separated on the driver shaft. the peek eyelet is closed for surgeons who prefer the traditional whipstitch technique. strong fixation is obtained by screwing the anchor body into the socket. the bioabsorbable fixation anchors are intended to be used for suture (soft tissue) fixation to bone in the foot, ankle, knee, hand, wrist, elbow, shoulder and hip.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

arthrex australia pty ltd - 45061 - fixation anchor, soft-tissue, biodegradable - the device is comprised of two sections, an absorbable anchor body of plla and ?tcp and a non-absorbable forked tip peek eyelet. the suture anchor is pre-mounted on a driver with the anchor body and eyelet physically separated on the driver shaft. strong fixation is obtained by screwing the anchor body into the socket. the bioabsorbable fixation anchors are intended to be used for suture (soft tissue) fixation to bone in the foot, ankle, knee, hand, wrist, elbow, shoulder and hip.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 45061 - fixation anchor, soft-tissue, biodegradable - this product is an absorbable bone fixation anchor that fixes soft tissues such as ligaments,tendons and the articular capsules to a bone and is used in orthopedic surgery. this product consists of an absorbable anchor, a non-absorbable suture, driver shaft and handle. genie? biocomposite knotless anchor is used for fixation of soft tissue to a bone, using suture in orthopedic surgery for shoulders and knees.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 45061 - fixation anchor, soft-tissue, biodegradable - this product is an absorbable bone fixation anchor that fixes soft tissues such as ligaments, tendons, and the articular capsules to a bone, and is used in orthopedic surgery. this product consists of an absorbable anchor, a non-absorbable suture, driver shaft, and handle. genie? biocomposite suture anchor is used for fixation of soft tissue to a bone, using suture in orthopedic surgery for shoulders and knees.

Singapūras - anglų - HSA (Health Sciences Authority)

transmedic pte ltd - polidocanol - injection - polidocanol 10mg/ml

Australija - anglų - Department of Health (Therapeutic Goods Administration)

boston scientific pty ltd - 45664 - embolization implant, chemotherapeutic - 2 mls of biocompatible, non-resorbable, hydrophilic microshperes in glass vial. 4 sizes of bead ranging from 100 - 900 um. note: variant not on variant list, selected size (mm) to enable submission. embolisation of vessels supplying malignant hypervascularised tumours and delivery of local, controlled, sustained doses of chemotherapeutic drugs to tumours. the drug is not supplied with the device.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

boston scientific pty ltd - 45664 - embolization implant, chemotherapeutic - dc beadm1 is a hydrogel bead, which is biocompatible, hydrophilic, non resorbable, size calibrated and capable of loading and eluting doxorubicin or irinotecan prior to embolisation and then as a secondary action, elute a local, controlled and sustained dose to the tumour after embolization. the drugs are not supplied with the device. the dc bead m1 is primarily intended as an embolic agent for the treatment of malignant colorectal cancer metastasised to the liver (mcrc) and hepatocellular carcinoma (hcc).

Australija - anglų - Department of Health (Therapeutic Goods Administration)

emergo asia pacific pty ltd t/a emergo australia - 16966 - graft, bone, synthetic - genex has been bioengineered to mimic human bone. one component of the matrix prevents soft tissue in-growth until it is resorbed and replaced by new bony issue. another component has been shown to act as a scaffold through which new bone grows. genex is a simple to use synthetic resorbable material designed to promote regeneration of bone in osseous defects. it degrades into component elements normally found in the body and is highly biocompatible.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

emergo asia pacific pty ltd t/a emergo australia - 16966 - graft, bone, synthetic - genex has been bioengineered to mimic human bone. one component of the matrix prevents soft tissue in-growth until it is resorbed and replaced by new bony tissue. another component has been shown to act as scaffold through which new bone grows. genex is a simple to use synthetic resorbable material designed to promote regeneration of bone in osseous defects. it degrades into component elements normally found in the body and is highly biocompatible.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

boston scientific pty ltd - 45664 - embolization implant, chemotherapeutic - dc bead lumi is a hydrogel bead, which is radiopaque, biocompatible, hydrophilic, non resorbable, size calibrated and capable of loading and eluting doxorubicin or irinotecan prior to embolisation and then as a secondary action, elute a local, controlled and sustained dose to the tumour after embolization. the drugs are not supplied with the device. dc bead lumi? can be used as an embolic agent with or without delivery of doxorubicin or irinotecan. unloaded dc bead lumi? is intended to be used for the embolisation of non-malignant hypervascular tumors and arteriovenous malformations (avms).dc bead lumitm is primarily intended as an embolic agent for the local treatment of malignant hypervascularised tumour(s) in the liver. dc bead lumitm is compatible with doxorubicin for the local treatment of tumours in patients with hepatocellular carcinoma. doxorubicin can be loaded prior to embolisation and, as a secondary action, the beads will elute a local, controlled and sustained dose to the tumour after embolisation. dc bead lumitm is also intended to embolise the vessels supplying malignant colorectal cancer metastasised to the liver (mcrc). dc bead lumitm is compatible with irinotecan which can be loaded prior to embolisation and then, as a secondary action, the beads will elute a local, controlled and sustained dose to the mcrc after embolisation.